← Back to Clinical Trials
Recruiting NCT07360093

PENG Block & PENG PRF

Trial Parameters

Condition Osteoarthritis (OA) of the Hip
Sponsor Ankara City Hospital Bilkent
Study Type OBSERVATIONAL
Phase N/A
Enrollment 84
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2026-02-01
Completion 2027-02-01
Interventions
PENG Block Pulsed radiofrequency

Brief Summary

The primary aim of this study is to prospectively compare the effects of the pericapsular nerve group (PENG) block alone and the combination of PENG block with pulsed radiofrequency (PRF) on pain intensity in patients with chronic hip pain. As a secondary aim, the effects of both treatment modalities on hip function are intended to be evaluated using valid and reliable functional assessment scales. Through this study, it is aimed to demonstrate the clinical contribution of adding PRF to the PENG block and to identify a more effective and longer-lasting approach for the interventional treatment of chronic hip pain.

Eligibility Criteria

Inclusion Criteria: * Presence of chronic hip pain lasting at least 3 months * Baseline Visual Analog Scale (VAS) score ≥ 4 * Clinical and/or radiological diagnosis of hip osteoarthritis * Inadequate response to conservative treatments Exclusion Criteria: * Local or systemic infection at the intervention site * Coagulopathy or inability to discontinue anticoagulant therapy * Hip pain related to malignancy * History of previous hip arthroplasty * Severe neurological deficit * Pregnancy or breastfeeding

Related Trials